Predictive Biosciences, Affinity Collaborate on Assay Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Predictive Biosciences and Affinity Life Sciences today said they are collaborating to develop biomarker assays for use in clinical studies.

Financial and other terms of the deal were not disclosed.

In a statement, Predictive Bio, based in Lexington, Ky., said the collaboration provides it with access to Affinity's expertise in biomarker immunoassay development. It added that with Affinity's support it will expand its cancer diagnostic menu.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.